Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-04-26

Clinical Trial Update: Efficacy of Diclofenac Potassium vs Nimesulide in the Treatment of Fever and Pain in Children With Upper Respiratory Tract Infection [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing diclofenac potassium to nimesulide for fever and pain in children with upper respiratory tract infections has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DICLOFENAC POTASSIUM (diclofenac potassium)
  • nimesulide (nimesulide)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Upper Respiratory Tract Infections | Phase 4 | Status: WITHDRAWN